Identifying enriched drug fragments as possible candidates for metabolic engineering

Sunandini Sharma, Kritika Karri, Ishwor Thapa, Dhundy Raj Bastola, Dario Ghersi

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Fragment-based approaches have now become an important component of the drug discovery process. At the same time, pharmaceutical chemists are more often turning to the natural world and its extremely large and diverse collection of natural compounds to discover new leads that can potentially be turned into drugs. In this study we introduce and discuss a computational pipeline to automatically extract statistically overrepresented chemical fragments in therapeutic classes, and search for similar fragments in a large database of natural products. By systematically identifying enriched fragments in therapeutic groups, we are able to extract and focus on few fragments that are likely to be active or structurally important. Results: We show that several therapeutic classes (including antibacterial, antineoplastic, and drugs active on the cardiovascular system, among others) have enriched fragments that are also found in many natural compounds. Further, our method is able to detect fragments shared by a drug and a natural product even when the global similarity between the two molecules is generally low. Conclusions: A further development of this computational pipeline is to help predict putative therapeutic activities of natural compounds, and to help identify novel leads for drug discovery.

Original languageEnglish (US)
Article number46
JournalBMC Medical Genomics
Volume9
DOIs
StatePublished - Oct 8 2016

Fingerprint

Metabolic Engineering
Drug Discovery
Biological Products
Pharmaceutical Preparations
Therapeutics
Cardiovascular System
Antineoplastic Agents
Databases

Keywords

  • Chemoinformatics
  • Metabolic engineering
  • Natural products
  • Small molecules

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Identifying enriched drug fragments as possible candidates for metabolic engineering. / Sharma, Sunandini; Karri, Kritika; Thapa, Ishwor; Bastola, Dhundy Raj; Ghersi, Dario.

In: BMC Medical Genomics, Vol. 9, 46, 08.10.2016.

Research output: Contribution to journalArticle

@article{3c6308ab829644daaa6823df1fa0a08f,
title = "Identifying enriched drug fragments as possible candidates for metabolic engineering",
abstract = "Background: Fragment-based approaches have now become an important component of the drug discovery process. At the same time, pharmaceutical chemists are more often turning to the natural world and its extremely large and diverse collection of natural compounds to discover new leads that can potentially be turned into drugs. In this study we introduce and discuss a computational pipeline to automatically extract statistically overrepresented chemical fragments in therapeutic classes, and search for similar fragments in a large database of natural products. By systematically identifying enriched fragments in therapeutic groups, we are able to extract and focus on few fragments that are likely to be active or structurally important. Results: We show that several therapeutic classes (including antibacterial, antineoplastic, and drugs active on the cardiovascular system, among others) have enriched fragments that are also found in many natural compounds. Further, our method is able to detect fragments shared by a drug and a natural product even when the global similarity between the two molecules is generally low. Conclusions: A further development of this computational pipeline is to help predict putative therapeutic activities of natural compounds, and to help identify novel leads for drug discovery.",
keywords = "Chemoinformatics, Metabolic engineering, Natural products, Small molecules",
author = "Sunandini Sharma and Kritika Karri and Ishwor Thapa and Bastola, {Dhundy Raj} and Dario Ghersi",
year = "2016",
month = "10",
day = "8",
doi = "10.1186/s12920-016-0205-6",
language = "English (US)",
volume = "9",
journal = "BMC Medical Genomics",
issn = "1755-8794",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Identifying enriched drug fragments as possible candidates for metabolic engineering

AU - Sharma, Sunandini

AU - Karri, Kritika

AU - Thapa, Ishwor

AU - Bastola, Dhundy Raj

AU - Ghersi, Dario

PY - 2016/10/8

Y1 - 2016/10/8

N2 - Background: Fragment-based approaches have now become an important component of the drug discovery process. At the same time, pharmaceutical chemists are more often turning to the natural world and its extremely large and diverse collection of natural compounds to discover new leads that can potentially be turned into drugs. In this study we introduce and discuss a computational pipeline to automatically extract statistically overrepresented chemical fragments in therapeutic classes, and search for similar fragments in a large database of natural products. By systematically identifying enriched fragments in therapeutic groups, we are able to extract and focus on few fragments that are likely to be active or structurally important. Results: We show that several therapeutic classes (including antibacterial, antineoplastic, and drugs active on the cardiovascular system, among others) have enriched fragments that are also found in many natural compounds. Further, our method is able to detect fragments shared by a drug and a natural product even when the global similarity between the two molecules is generally low. Conclusions: A further development of this computational pipeline is to help predict putative therapeutic activities of natural compounds, and to help identify novel leads for drug discovery.

AB - Background: Fragment-based approaches have now become an important component of the drug discovery process. At the same time, pharmaceutical chemists are more often turning to the natural world and its extremely large and diverse collection of natural compounds to discover new leads that can potentially be turned into drugs. In this study we introduce and discuss a computational pipeline to automatically extract statistically overrepresented chemical fragments in therapeutic classes, and search for similar fragments in a large database of natural products. By systematically identifying enriched fragments in therapeutic groups, we are able to extract and focus on few fragments that are likely to be active or structurally important. Results: We show that several therapeutic classes (including antibacterial, antineoplastic, and drugs active on the cardiovascular system, among others) have enriched fragments that are also found in many natural compounds. Further, our method is able to detect fragments shared by a drug and a natural product even when the global similarity between the two molecules is generally low. Conclusions: A further development of this computational pipeline is to help predict putative therapeutic activities of natural compounds, and to help identify novel leads for drug discovery.

KW - Chemoinformatics

KW - Metabolic engineering

KW - Natural products

KW - Small molecules

UR - http://www.scopus.com/inward/record.url?scp=84981272717&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981272717&partnerID=8YFLogxK

U2 - 10.1186/s12920-016-0205-6

DO - 10.1186/s12920-016-0205-6

M3 - Article

C2 - 27510651

AN - SCOPUS:84981272717

VL - 9

JO - BMC Medical Genomics

JF - BMC Medical Genomics

SN - 1755-8794

M1 - 46

ER -